Bariatric surgery and Mounjaro highlighted as effective weight‑loss treatments

Bariatric surgery, including gastric sleeve and bypass, reshapes the digestive tract to alter gut hormones, reduce hunger, and improve metabolic conditions such as type 2 diabetes and cardiovascular risk. The procedures are most effective when paired with long‑term lifestyle changes and are increasingly sought in Melbourne, Australia.

Mounjaro, a GLP‑1/GIP receptor agonist, works by modulating hormonal pathways that control appetite, satiety and energy balance. Clinical discussion in Abu Dhabi, United Arab Emirates, emphasizes its role in promoting steady, sustainable weight loss, reducing irregular eating patterns and supporting gradual metabolic adjustment without rapid weight fluctuations.

Both approaches aim to address the hormonal drivers of obesity rather than relying solely on calorie restriction, offering patients more durable improvements in metabolic health.